Biophytis S.A. (BPTSY)

Biophytis S.A. (BPTSY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $17.5M; returns 1 day +0.0%, 1 week +0.0%.

Biophytis S.A. is a clinical-stage biotechnology company specializing in therapies for age-related degenerative diseases and muscle wasting. The company's business model is centered on its proprietary drug discovery platform and the development of its lead compound, BIO101 (Sarconeos), which targets the MAS receptor to stimulate muscle function and respiratory capacity.

Groups BPTSY belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Life Sciences
• Aging Population Needs
• Pharmaceuticals
• Metabolic Disorders
• Weight Management
• GLP-1 Agonists

BPTSY financial model: income statement, cash flow and balance sheet